Royce & Associates’s ICU Medical ICUI Stock Holding History

Royce & Associates’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,968	Closed	-$2.54M	–	1178
2018 Q3	$2.54M	Sell	8,968 -31,000	-78%	-$9.08M	0.02%	785
2018 Q2	$11.7M	Sell	39,968 -1,700	-4%	-$465K	0.08%	345
2018 Q1	$10.5M	Sell	41,668 -800	-2%	-$188K	0.07%	373
2017 Q4	$9.17M	Sell	42,468 -4,932	-10%	-$998K	0.06%	423
2017 Q3	$8.81M	Hold	47,400	–	–	0.06%	416
2017 Q2	$8.18M	Buy	47,400 +10,000	+27%	+$1.6M	0.05%	445
2017 Q1	$5.71M	Buy	+37,400	New	+$5.47M	0.04%	537
2015 Q1	–	Sell	-700	Closed	-$57K	–	1263
2014 Q4	$57K	Hold	700	–	–	﹤0.01%	1246
2014 Q3	$45K	Hold	700	–	–	﹤0.01%	1351
2014 Q2	$43K	Hold	700	–	–	﹤0.01%	1386
2014 Q1	$42K	Hold	700	–	–	﹤0.01%	1384
2013 Q4	$45K	Sell	700 -15,600	-96%	-$1M	﹤0.01%	1396
2013 Q3	$1.11M	Sell	16,300 -7,000	-30%	-$500K	﹤0.01%	1163
2013 Q2	$1.68M	Buy	+23,300	New	+$1.54M	0.01%	1080

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royce & Associates's ICUI Position: Q4 2018 in Review

Royce & Associates sold out of ICU Medical (ICUI) in Q4 2018, closing a stake of 8,968 shares — an estimated $2.54M sold.

Royce & Associates first reported a position in ICUI in Q2 2013 and held it in 14 quarters. The position peaked at $11.7M in Q2 2018. 294 funds tracked by Wall St. Rank hold ICUI as of Q4 2018.

Royce & Associates reported no remaining ICU Medical position as of Q4 2018 after selling out during the quarter.
Royce & Associates sold 8,968 ICU Medical shares in Q4 2018, an estimated $2.54M.
Royce & Associates first reported a position in ICU Medical in Q2 2013 and held it in 14 quarters.
Royce & Associates's ICU Medical position peaked at $11.7M in Q2 2018.
294 funds tracked by Wall St. Rank held ICU Medical as of Q4 2018.

Based on Royce & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.